Star Human Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 23.22%
- Profit Growth 33.57%
- Ebitda -42.25%
- Net Worth 19.37%
- Total Assets 9.01%
About Star Human Sciences
Star Human Sciences Private Limited (SHSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 February 2014 and has a history of Ten years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Tandon and Reema Tandon serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100DL2014PTC265415
- Company No.
265415
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Star Human Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Tandon  | Director | 26-Feb-2014 | Current |
| Reema Tandon | Director | 26-Feb-2014 | Current |
Financial Performance of Star Human Sciences.
Star Human Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.22% increase. The company also saw a substantial improvement in profitability, with a 33.57% increase in profit. The company's net worth Soared by an impressive increase of 19.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Star Human Sciences?
In 2021, Star Human Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Star Biomed Private LimitedSunil Tandon and Reema Tandon are mutual person
Starlabs Ivd Private LimitedSunil Tandon and Reema Tandon are mutual person
- Starbio Med Sciences Llp
Sunil Tandon is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Star Human Sciences?
Star Human Sciences has a workforce of 3 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Star Human Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Star Human Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
